Literature DB >> 2472799

Neonatal dural sinus thrombosis.

M I Shevell1, K Silver, A M O'Gorman, G V Watters, J L Montes.   

Abstract

Dural sinus thrombosis in the newborn period has been infrequently documented and its clinical presentation remains obscure. Seventeen patients, all of whom were born at term with dural sinus thrombosis diagnosed in the neonatal period, were retrospectively identified and reviewed. Diagnosis was determined by unenhanced computed tomography which demonstrated a dense sagittal sinus with concomitant small ventricles. Two patients had ancillary studies (i.e., cerebral angiography and nuclear flow scan) which confirmed the diagnosis. Only 4 patients had evidence of perinatal asphyxia. Three patients were identified as having associated conditions known to predispose them to dural sinus thrombosis. None of the patients tested had an identifiable hypercoagulable state. Neonatal seizures were the initial presentation in 15 patients. Seizure onset predominantly occurred during the first week of life. Subsequent examinations were available in all 17 patients and ranged up to 6 years. Only 3 patients had seizures beyond the neonatal period. In 11 of 12 infants with no history of perinatal asphyxia, neurodevelopmental outcomes were normal. Two of 4 infants with perinatal asphyxia had neurologic sequelae. Dural sinus thrombosis represents an important and under-recognized cause of neonatal seizures in term infants. In the absence of perinatal asphyxia, normal neuro-developmental outcome is likely and the risk of seizure recurrence is low.

Entities:  

Mesh:

Year:  1989        PMID: 2472799     DOI: 10.1016/0887-8994(89)90065-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

1.  2D time-of-flight MR venography in neonates: anatomy and pitfalls.

Authors:  E Widjaja; M Shroff; S Blaser; S Laughlin; C Raybaud
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Cerebral sinovenous thrombosis in pediatric practice.

Authors:  Gary L Hedlund
Journal:  Pediatr Radiol       Date:  2012-12-01

4.  A prospective outcome study of neonatal cerebral sinovenous thrombosis.

Authors:  Mahendranath D Moharir; Manohar Shroff; Ann-Marie Pontigon; Rand Askalan; Ivanna Yau; Daune Macgregor; Gabrielle A Deveber
Journal:  J Child Neurol       Date:  2011-05-31       Impact factor: 1.987

5.  Neonatal cerebral venous thrombosis coexisting with bilateral adrenal hemorrhage.

Authors:  E Ergenekon; K Gücüyener; Y Atalay; A Serdaroğlu; T Tali; E Koç; C Türkyilmaz
Journal:  Indian J Pediatr       Date:  2000-08       Impact factor: 1.967

6.  Pediatric stroke: a review.

Authors:  Daniel S Tsze; Jonathan H Valente
Journal:  Emerg Med Int       Date:  2011-12-27       Impact factor: 1.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.